Qube Research & Technologies (QRT)
TVRD

Qube Research & Technologies (QRT)’s Tvardi Therapeutics TVRD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,240
Closed -$13.7K – 3886
2024
Q3 		$13.7K Sell
1,240
-610
-33% -$7.15K ﹤0.01% 3006
2024
Q2 		$17.2K Buy
+1,850
New +$44.1K ﹤0.01% 2902
2023
Q4 		– Sell
-92
Closed -$5.55K – 4833
2023
Q3 		$5.55K Sell
92
-2,318
-96% -$217K ﹤0.01% 3433
2023
Q2 		$246K Buy
2,410
+1,989
+472% +$274K ﹤0.01% 1722
2023
Q1 		$74.4K Buy
+421
New +$141K ﹤0.01% 2178
2022
Q4 		– Sell
-874
Closed -$295K – 3090
2022
Q3 		$295K Sell
874
-1,226
-58% -$444K ﹤0.01% 1629
2022
Q2 		$690K Buy
2,100
+1,627
+344% +$571K 0.01% 1284
2022
Q1 		$207K Buy
+473
New +$194K ﹤0.01% 1934

Other funds holding TVRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TVRD Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of Tvardi Therapeutics (TVRD) in Q4 2024, closing a stake of 1,240 shares — an estimated $13.7K sold.

Qube Research & Technologies (QRT) first reported a position in TVRD in Q1 2022 and held it in 8 quarters. The position peaked at $690K in Q2 2022. 43 funds tracked by Wall St. Rank hold TVRD as of Q4 2024.

  • Qube Research & Technologies (QRT) reported no remaining Tvardi Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,240 Tvardi Therapeutics shares in Q4 2024, an estimated $13.7K.
  • Qube Research & Technologies (QRT) first reported a position in Tvardi Therapeutics in Q1 2022 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s Tvardi Therapeutics position peaked at $690K in Q2 2022.
  • 43 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.